Pharma Journalist 8801 posts 0 comments

SMi Reports: Interview with Matts Ramstorp, Professor in Cleanroom Technology, BioTekPro, chairing the upcoming SMi’s 2nd Annual Next Generation Pharmaceutical Cleanroom in London on 7…
Read More...

Tonix Pharmaceuticals Holding Corp. announced it has entered into a research collaboration and option agreement with Columbia University focused on studying the immune responses to…
Read More...

Catalent and Humanigen, Inc. announced the expansion of their relationship, under which Catalent will provide development, manufacturing and commercialization services for lenzilumab,…
Read More...

Oncorus, Inc., a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, announced a clinical trial collaboration agreement with Merck,…
Read More...

Novartis announced a new initiative to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms of COVID-19 – a…
Read More...

Boehringer Ingelheim announced that the European Commission (EC) has approved an additional indication for nintedanib in adults for the treatment of other chronic fibrosing interstitial…
Read More...

Orchard Therapeutics announced that the company has entered into two worldwide royalty-bearing license agreements with GlaxoSmithKline plc (GSK) for use of their proprietary lentiviral…
Read More...

SMi reports: Dr. Thakur Raghu Raj Singh from Queen’s University Belfast will lead the post conference workshop on Wednesday 25th November 2020. SMi presents the 4th Annual Ophthalmic…
Read More...

BioAegis Therapeutics Inc., announces that it received regulatory clearance from The Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of…
Read More...

Novocure announced it has entered into a clinical trial collaboration agreement with MSD (a tradename of Merck & Co., Inc.), through a subsidiary, to develop Tumor Treating Fields…
Read More...